Clinical Trials Logo

Growth Acceleration clinical trials

View clinical trials related to Growth Acceleration.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04506541 Completed - Clinical trials for Breastfeeding, Exclusive

The Effects Of KC On Exclusively Breastfeeding And Baby's Growth And Development According To Attachment Theory

Start date: March 1, 2017
Phase: N/A
Study type: Interventional

Kangaroo care is a developmental care method determined to improve the quality of life of premature babies. When the benefits of kangaroo care on development and feeding with breast milk on premature babies are considered, term babies should also receive kangaroo care, and kangaroo care should be started immediately after birth. In this research, the authors aimed to investigate the effect of kangaroo care at birth on breast milk only feeding status and infant growth and development according to attachment theory. This is a randomized controlled, experimental, prospective study. The sample of the study consisted of pregnant women between 36-38 gestational weeks, who referred to the pregnant outpatient clinic of Buca Maternity and Children Hospital between March 2017 and February 2019 (n: 132). Pregnant women in the intervention group received "kangaroo care and breastfeeding training," and their babies were given kangaroo care at birth. Routine care was given to the mothers and their babies in the control group. Maternal attachment levels of mothers in both groups after birth and infants' breastfeeding only status and infant growth and development in the first, third, sixth, and ninth months were evaluated.

NCT ID: NCT03574350 Completed - Preterm Infant Clinical Trials

Effect on Early Somatic Growth of a Daily Kinesthetic Stimulation on Preterm Infants

KISONKAP
Start date: August 15, 2013
Phase: N/A
Study type: Interventional

Kangaroo position (KP), the essential component of the Kangaroo Mother Care (KMC) method, has been increasingly implemented, given the benefits of early skin-to-skin contact on the cerebral maturation of preterm infants. In addition it allows for parents to bond with their infants and humanize the care of fragile infants in neonatal units. Evidence on kinesthetic stimulation (KS) is scarce and currently there is no available evidence on KS during the KP. KS is associated with massage in this paper

NCT ID: NCT03384719 Completed - Growth Acceleration Clinical Trials

The Effect of Milk Protein vs Blends of Milk and Plant Protein on Growth Markers in 7-8 Year Old Healthy Danish Children

PROGRO
Start date: January 18, 2018
Phase: N/A
Study type: Interventional

The purpose of PROGRO is to determine which combinations of milk and plant proteins are optimal to promote growth factors in children

NCT ID: NCT02586571 Completed - Adiposity Clinical Trials

Growth and Body Composition in Breastfed Infants - Study on Age of Introduction of Complementary Foods in Iceland

IceAge2
Start date: December 2014
Phase:
Study type: Observational

The purpose of this prospective cohort study is to investigate breast-milk and breastfeeding among infants who are exclusively and partially breastfed at 6 months of age in terms of characteristics that are hypothesised to contribute to growth and development of body composition in infancy. The scientific originality lies in the simultaneous sampling of multiple factors that are believed to contribute to growth and development of body composition in infancy, i.e. energy content of breast-milk, metabolism-regulating hormones in breast-milk, infant temperament and appetite. The selection of two predefined study groups, i.e. infants exclusively breastfed until 6 months of age and infants given complementary foods in addition to breast-milk from 3-4 months of age, gives the opportunity to describe, and perhaps up to some point compare, what now is described by the World Health Organization and in official Icelandic infant recommendations as "optimal feeding" and what studies have suggested is "common feeding" in many countries. The methods are carefully chosen, i.e. appropriate and non-invasive isotopes and validated questionnaires are used. To our knowledge, no study has reported breast-milk composition in exclusively vs. partially breastfed infants.

NCT ID: NCT02484495 Completed - Infant Morbidity Clinical Trials

Extended Pilot Project Community Based Production of Complementary Food in Ethiopia

Start date: March 2015
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the impact of a package of interventions including production and distribution of locally produced complementary foods (via so-called "Grain-banks") and Micronutrient Powders (MNPs) supplementation, and optimized food based Complementary Feeding Recommendation, on growth and micronutrient status of infants and young children. The impact of the intervention package will be evaluated in a quasi-experimental matched-control cluster design in infants and young children between 6 - 29 months of age. The impact, outcome, and output indicators of infants/children will be assessed in cross-sectional samples at baseline, after 9 and 18 months. A total of60 pair clusters are selected in which 15 households per cluster will be identified from the eligible population. A total of 1800 children from intervention and match-controlled clusters, will be sampled in the target age groups. Qualitative and quantitative data will be collected to gather information on Knowledge, Attitude and Practice (KAP), Infant and Young Child Feeding practices, anthropometry and anemia, following the impact pathway developed for the study. Research questions to be answered in this program evaluation are: 1. What impact does the extended pilot (implementation of local complementary food production and MNP) have on: 1. Growth in children 17-29 months of age 2. Infant and Young Child Feeding practices in children (6-23m), and 3. Anemia status in children 11-23 m? 2. What are determining factors for the impact/no impact related to: 1. Immediate outcomes: skills and capacity; knowledge, attitude and practices; and improved access 2. Intermediate outcomes: utilization; provision, and ensuring enabling environment 3. Program performance as measured by program monitoring data on output and activities?

NCT ID: NCT02403739 Completed - Growth Retardation Clinical Trials

Visual Interpretation of Neonatal Growth Charts

Start date: March 2015
Phase: N/A
Study type: Observational

Simulated growth data will be shown to clinicians in two formats - (1) as weight vs.age charts, (2) as weight Z-score vs. age charts. Clinicians will be asked to identify whether growth is too fast, too slow, or normal. The test will take a total of 10 minutes.

NCT ID: NCT02239588 Completed - Growth Acceleration Clinical Trials

Evaluation of the Effect of Pure Canterbury Stage 1 Infant Formula Milk Powder on the Growth of Infant 0-6 Months of Age

Start date: April 2014
Phase: Phase 4
Study type: Interventional

This was a randomized, double-blind, single-center, placebo-controlled, three-arm study, with a 12-week intervention period. The objectives of this study were to evaluate the effect of Pure Canterbury Stage 1 (0-6 months) milk powder on: 1. Bone health; 2. Infants growth; 3. Intestinal health; 4. Gastrointestinal tolerance to the test product; g) Incidence of Eczema

NCT ID: NCT02170428 Completed - Clinical trials for Overweight or Obesity

Diet and Well-being of Young Danish Children

SKOT I
Start date: May 2007
Phase:
Study type: Observational

The overall objective with the study was to contribute to the scientific basis for dietary and life strategies, policies and dietary guidelines to infants and young children in Denmark and with special focus on prevention of obesity and diet related chronic diseases such as type 2 diabetes, ischemic heart disease and osteoporosis.

NCT ID: NCT01489098 Completed - Growth Acceleration Clinical Trials

Effect of the Level of Dietary Protein on Body Composition

Start date: September 2011
Phase: N/A
Study type: Observational

The purpose of this study is to determine if toddlers and children who were fed breast milk or infant formulas at different levels of protein between 3 and 12 months of age have differences in growth and body composition at 3 and 5 years of age.